biotin has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies
Studies (biotin) | Trials (biotin) | Recent Studies (post-2010) (biotin) | Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) |
---|---|---|---|---|---|
14,847 | 95 | 3,882 | 9,156 | 187 | 552 |
Protein | Taxonomy | biotin (IC50) | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) |
---|---|---|---|
Platelet-activating factor receptor | Homo sapiens (human) | 0.0003 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoki, J; Ebina, K; Kumagai, T; Sato, A | 1 |
1 other study(ies) available for biotin and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Article | Year |
---|---|
Synthetic biotinylated peptide compounds derived from Asp-hemolysin: novel potent inhibitors of platelet-activating factor.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Biotin; Biotinylation; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Fungal Proteins; Hemolysin Proteins; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Male; Peptide Fragments; Peptides; Platelet Activating Factor; Rats; Rats, Wistar | 2012 |